Atlas Trials

Tezosentan in Patients With Pulmonary Arterial Hypertension

Clinical trial NCT01094067 · TERMINATED

Trial details

NCT number
NCT01094067
Sponsor
Idorsia Pharmaceuticals Ltd.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Pulmonary Arterial Hypertension
Start date
2010-09-01
Primary completion
2010-12-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.